Virtual Intensive Outpatient Program for Alcoholism

Centre for Addiction and Mental Health, Toronto, Canada
AlcoholismVirtual Intensive Outpatient Program - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial aims to offer a virtual intensive outpatient program for people with alcohol use disorder to help them reduce their drinking and improve their health.

Eligible Conditions
  • Alcoholism

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Similar Trials

1
Suvorexant Treatment
1
Pioglitazone
1
Broad-Spectrum Cannabidiol

Study Objectives

2 Primary · 11 Secondary · Reporting Duration: 28 days

28 Days
Retention in treatment
28 days
Change in Anxiety Symptoms during the IOP Assessed Using the Generalized Anxiety Disorder-7 (GAD-7)
Change in Depressive Symptoms during the IOP Assessed Using the Patient Health Questionnaire-9 (PHQ-9)
Change in Emotion Regulation During the IOP Assessed Using the Difficulties in Emotion Regulation Scale (DERS)
Change in Emotion Regulation During the IOP Assessed Using the Emotion Regulation Questionnaire (ERQ)
Change in Quality of Life during the IOP Assessed Using the Abbreviated World Health Organization Quality of Life Scale (WHOQOL-BREF)
Change in Self-Reported Alcohol Craving During the IOP Assessed by the Penn Alcohol Craving Scale (PACS)
Change in Sleep during the IOP Assessed Using the Pittsburgh Sleep Quality Index (PSQI)
Changes in Average Drinks Per Day During the IOP Assessed by the Timeline Followback Interview (TLFB)
Changes in Number of Abstinence Days During the IOP Assessed by the Timeline Followback Interview (TLFB)
Changes in Number of Binge Drinking Days During the IOP Assessed by the Timeline Followback Interview (TLFB)
Satisfaction with Telemedicine Delivery as Assessed by a modified version of the Telehealth Satisfaction Scale (TESS)
Satisfaction with treatment as assessed by the Client Satisfaction Questionnaire-8 (CSQ-8)

Trial Safety

Phase-Based Safety

1 of 3

Similar Trials

1
Suvorexant Treatment
1
Pioglitazone
2
Broad-Spectrum Cannabidiol

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

Virtual Intensive Outpatient Program
1 of 1

Experimental Treatment

63 Total Participants · 1 Treatment Group

Primary Treatment: Virtual Intensive Outpatient Program · No Placebo Group · N/A

Virtual Intensive Outpatient Program
Other
Experimental Group · 1 Intervention: Virtual Intensive Outpatient Program · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 28 days

Who is running the clinical trial?

Centre for Addiction and Mental HealthLead Sponsor
330 Previous Clinical Trials
77,295 Total Patients Enrolled
14 Trials studying Alcoholism
3,216 Patients Enrolled for Alcoholism
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,268 Previous Clinical Trials
25,601,512 Total Patients Enrolled
3 Trials studying Alcoholism
472 Patients Enrolled for Alcoholism

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You agree to stop drinking alcohol during the month-long treatment period. However, you can still work towards reducing your alcohol intake in the long run.
You drink a lot of alcohol, which means you have more than 10 drinks per week if you are female or more than 15 drinks per week if you are male. You also have at least one day per week where you drink a lot in a short period of time, which is defined as having 4 or more drinks if you are female or 5 or more drinks if you are male in a single day.
References

Frequently Asked Questions

Is this research initiative currently open to participants?

"Clinicaltrials.gov states that this research endeavor is presently recruiting participants, having initially been posted on January 30th 2023 and recently revised as of February 1st 2023." - Anonymous Online Contributor

Unverified Answer

How many individuals are currently undergoing this clinical research?

"Affirmative. According to the information shared on clinicaltrials.gov, recruitment for this medical study is open and ongoing since its posting date of January 30th 2023. It requires 63 participants from a single site and has most recently been updated on February 1st 2023." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top